Journals / Journal of Clinical and Experimental Investigations / 2013 / Cilt: 4 - Sayı: 2

Magnezyum: Kalsiyum kanal antagonisti olarak göz sağlığı üzerindeki etkileri

Magnesium: Effect on ocular health as a calcium channel antagonist

Pages
244–251
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Magnesiumdeficiency has been shown to cause increased lenticularoxidative stress and ionic imbalance in the lens so triggercataractogenesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Magnesium is the physiologic calcium channel blocker,involving in many different metabolic processes by main-taining cell membrane function, modulating smooth mus-cle contraction and influencing enzymatic activities.
📊
Key Findings & Data:Mag-nesium has been shown to increase blood flow to tissuesby modifying endothelial function via endothelin-1 (ET-1)and nitric Oxide (NO) pathways.
💡
Conclusion & Impact:Magnesiumdeficiency has been shown to cause increased lenticularoxidative stress and ionic imbalance in the lens so triggercataractogenesis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Magnesium is the physiologic calcium channel blocker,involving in many different metabolic processes by main-taining cell membrane function, modulating smooth mus-cle contraction and influencing enzymatic activities. Mag-nesium has been shown to increase blood flow to tissuesby modifying endothelial function via endothelin-1 (ET-1)and nitric Oxide (NO) pathways. Magnesium also exhib-its neuroprotective role by blocking N-methyl-D-aspartate(NMDA) receptor related calcium influx and by inhibitingthe release of glutamate, hence protects the cell againstoxidative stress and apoptosis. Both increase in bloodflow and its neuroprotective effect make magnesium agood candidate for glaucoma studies. Magnesium hasbeen shown to decrease oxidative stress and apoptosisin retinal tissue and to have retinal ganglion cell spar-ing effect. A series of studies has been conducted aboutmagnesium could decrease insulin resistance in diabeticpatients, ease glycemia control and prevent diabetic reti-nopathy. Magnesium is found to be critically important inmaintaining normal ionic homeostasis of lens. Magnesiumdeficiency has been shown to cause increased lenticularoxidative stress and ionic imbalance in the lens so triggercataractogenesis.

Özet

Magnezyum hücre zar fonksiyonlarını, düz kas kontrak-siyonlarını ve enzimatik reaksiyonları etkileyerek pekçok metabolik sürece katılan fizyolojik bir kalsiyum kanal blokörüdür. Magnezyumun Endothelin-1 (ET-1) ve NitrikOksit (NO) yolakları vasıtasıyla endotel fonksiyonlrını modifiye ederek dokulara kan akımında artışa neden olduğu gösterilmiştir. Magnezyum aynı zamanda N-me- til-D-aspartat (NMDA) reseptör ilişkili kalsiyum içe akımı- nı bloke ederek ve glutamat serbestleşmesini önleyereknöroprotektif rol oynamakta ve hücreleri oksidatif stres veapoptoza karşı korumaktadır. Hem kan akımında artışa neden olması hem de nöroprotektif etkileri magnezyumuglokom çalışmaları için iyi bir hedef molekül yapmaktadır. Magnezyumun retinada oksidatif stresi ve apoptozu azalt-tığı ve ganglion koruyucu etkileri olduğu gösterilmiştir. Bir takım çalışmalarda aynı zamanda magnezyumun diabe- tik hastalarda insulin resistansını azalttığı, glisemik kont- rolü kolaylaştırdığı ve retinopatiyi önlediği gösterilmiştir. Magnezyumun lensteki iyon dengesinin sağlanmasındakritik önemi belirlenmiştir. Magnezyum eksikliğinin lentiküler oksidatif stresi arttırdığı ve iyon dengesini bozarak katarakt oluşumuna neden olduğu gösterilmiştir.

🔖

Cite This Article

AYDIN, B., TUFAN, H. A., KORKMAZ, Ş., EKİCİ, F. (2022). Magnezyum: Kalsiyum kanal antagonisti olarak göz sağlığı üzerindeki etkileri. Journal of Clinical and Experimental Investigations, Cilt: 4 - Sayı: 2, 244–251. https://ajindex.com/articles/561855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Wester PO. Magnesium. Am J Clin Nutr 1987;45:1305- 1312
  2. Saris NEL, Mervaala E, Karppanen H. Magnesium; An update on physiological, clinical and analytical as- pects. Clin Chim Acta 2000;294:1-26
  3. Cowan JA. The biological chemistry of magnesium, 1st edn. New York: Wiley-VCH, 1995:5-7
  4. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J 1984;108:188-193
  5. Levine BS, Coburn JW. Magnesium, the mimic antago- nist of calcium. N Engl J Med 1984;310:1253-1255
  6. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Molecular Aspects of Medicine 2003;24:107-136
  7. Laurant P, Berthelot A. Endothelin-1-induced contrac- tion in isolated aortae from normotensive and DOCA- salt hypertensive rats: effect of magnesium. Br J Phar- macol 1996;119:1367-1374
  8. Berthon N, Laurant P, Hayoz D, et al. Magnesium sup- plementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1. Can J Physiol Pharm 2002;80:553-561
  9. Haenni A, Johansson K, Lind L, Lithell H. Magne- sium infusion improves endothelium-dependent va- sodilation in the human forearm. Am J Hypertens 2002;15:10-15
  10. Yang ZW, Gebrewold A, Nowakowski M, et al. Mg(2+)- induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: role of NO. Am J Physiol Regul Integr Comp Physiol 2000;278:628- 639
  11. Szabo C, Farago M, Dora E. Effect of small changes in extracellular magnesium concentration on the tone of feline mesenteric arteries: involvement of endothe- lium. Acta Physiol Hung 1992;79:295-303
  12. Barbagallo M, Dominquez LJ, Galioto A, et al. Oral magnesium supplementation improves vascular func- tion in elderly diabetic patients. Magnesium Research 2010;23:131-137
  13. Shechter M, Sharir M, Labrador MJ, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000;102:2353-2358
  14. Teragawa H, Kato M, Yamagata T, et al. Magnesium causes nitric oxide independent coronary artery vaso- dilation in humans. Heart. 2001;86:212-216
  15. Pyne GJ, Cadoux-Hudson TA, Clark JF. Magne- sium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 2001;15:409-415
  16. Shear R, Leduc L, Rey E, Moutquin JM. Hypertension in pregnancy. New recommendations for management. Curr Hypert Reports 1999;1:529-539
  17. Chaudhary P, Ahmed F, Sharma SC. MK801-a neu- roprotectant in rat hypert